Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?

Detalles Bibliográficos
Autores principales: Lwin, May, Holroyd, Christopher, Wallis, Dinny, Davidson, Brian, Goulston, Lyndsey, de Graaf, Hans, Edwards, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Letter to the Editor (Other)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661840/
https://www.ncbi.nlm.nih.gov/pubmed/33210076
http://dx.doi.org/10.1093/rap/rkaa061
_version_ 1783609278747115520
author Lwin, May
Holroyd, Christopher
Wallis, Dinny
Davidson, Brian
Goulston, Lyndsey
de Graaf, Hans
Edwards, Christopher J
author_facet Lwin, May
Holroyd, Christopher
Wallis, Dinny
Davidson, Brian
Goulston, Lyndsey
de Graaf, Hans
Edwards, Christopher J
author_sort Lwin, May
collection PubMed
description
format Online
Article
Text
id pubmed-7661840
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76618402020-11-16 Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs? Lwin, May Holroyd, Christopher Wallis, Dinny Davidson, Brian Goulston, Lyndsey de Graaf, Hans Edwards, Christopher J Rheumatol Adv Pract Letter to the Editor (Other) Oxford University Press 2020-10-21 /pmc/articles/PMC7661840/ /pubmed/33210076 http://dx.doi.org/10.1093/rap/rkaa061 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor (Other)
Lwin, May
Holroyd, Christopher
Wallis, Dinny
Davidson, Brian
Goulston, Lyndsey
de Graaf, Hans
Edwards, Christopher J
Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
title Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
title_full Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
title_fullStr Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
title_full_unstemmed Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
title_short Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?
title_sort does covid-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological dmards or targeted synthetic dmards?
topic Letter to the Editor (Other)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661840/
https://www.ncbi.nlm.nih.gov/pubmed/33210076
http://dx.doi.org/10.1093/rap/rkaa061
work_keys_str_mv AT lwinmay doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards
AT holroydchristopher doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards
AT wallisdinny doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards
AT davidsonbrian doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards
AT goulstonlyndsey doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards
AT degraafhans doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards
AT edwardschristopherj doescovid19causeanincreasedriskofhospitalizationordeathinpatientswithinflammatoryrheumaticdiseasestreatedwithbiologicaldmardsortargetedsyntheticdmards

Ejemplares similares